Global Biologics and Biosimilars Market Research Report 2023 (Status and Outlook)

Report ID: 2026566 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
TABLE OF CONTENTS
1 Research Methodology and Statistical Scope	1
1.1 Market Definition and Statistical Scope of Biologics and Biosimilars	1
1.2 Key Market Segments	1
1.2.1 Biologics and Biosimilars Segment by Type	1
1.2.2 Biologics and Biosimilars Segment by Application	2
1.3 Methodology & Sources of Information	3
1.3.1 Research Methodology	3
1.3.2 Research Process	4
1.3.3 Market Breakdown and Data Triangulation	5
1.3.4 Base Year	5
1.3.5 Report Assumptions & Caveats	6
2 Biologics and Biosimilars Market Overview	8
2.1 Global Market Overview	8
2.1.1 Global Biologics and Biosimilars Market Size (M USD) Estimates and Forecasts (2017-2028)	8
2.1.2 Global Biologics and Biosimilars Sales Estimates and Forecasts (2017-2028)	9
2.2 Market Segment Executive Summary	9
2.3 Global Market Size by Region	11
3 Biologics and Biosimilars Market Competitive Landscape	13
3.1 Global Biologics and Biosimilars Sales by Manufacturers (2017-2022)	13
3.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2017-2022)	15
3.3 Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)	16
3.4 Global Biologics and Biosimilars Average Price by Manufacturers (2017-2022)	17
3.5 Manufacturers Biologics and Biosimilars Sales Sites, Area Served, Product Type	18
3.6 Biologics and Biosimilars Market Competitive Situation and Trends	19
3.6.1 Biologics and Biosimilars Market Concentration Rate	19
3.6.2 Global 5 and 10 Largest Biologics and Biosimilars Players Market Share by Revenue	21
3.6.3 Mergers & Acquisitions, Expansion	21
4 Biologics and Biosimilars Industry Chain Analysis	22
4.1 Biologics and Biosimilars Industry Chain Analysis	22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials	22
4.3 Midstream Market Analysis	23
4.4 Downstream Customer Analysis	23
5 The Development and Dynamics of Biologics and Biosimilars Market	25
5.1 Key Development Trends	25
5.2 Driving Factors	25
5.3 Market Challenges	25
5.4 Market Restraints	26
5.5 Industry News	26
5.5.1 New Product Developments	26
5.5.2 Mergers & Acquisitions	26
5.5.3 Expansions	26
5.5.4 Collaboration/Supply Contracts	26
5.6 Industry Policies	26
6 Biologics and Biosimilars Market Segmentation by Type	27
6.1 Evaluation Matrix of Segment Market Development Potential (Type)	27
6.2 Global Biologics and Biosimilars Sales Market Share by Type (2017-2022)	28
6.3 Global Biologics and Biosimilars Market Size Market Share by Type (2017-2022)	29
6.4 Global Biologics and Biosimilars Price by Type (2017-2022)	30
7 Biologics and Biosimilars Market Segmentation by Application	31
7.1 Evaluation Matrix of Segment Market Development Potential (Application)	31
7.2 Global Biologics and Biosimilars Market Sales by Application (2017-2022)	32
7.3 Global Biologics and Biosimilars Market Size (M USD) by Application (2017-2022)	33
7.4 Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022)	34
8 Biologics and Biosimilars Market Segmentation by Region	35
8.1 Global Biologics and Biosimilars Sales by Region	35
8.1.1 Global Biologics and Biosimilars Sales by Region	35
8.1.2 Global Biologics and Biosimilars Sales Market Share by Region	35
8.2 North America	36
8.2.1 North America Biologics and Biosimilars Sales by Country	36
8.2.2 U.S.	37
8.2.3 Canada	37
8.2.4 Mexico	37
8.3 Europe	37
8.3.1 Europe Biologics and Biosimilars Sales by Country	38
8.3.2 Germany	38
8.3.3 France	38
8.3.4 U.K.	38
8.3.5 Italy	39
8.3.6 Russia	39
8.4 Asia Pacific	39
8.4.1 Asia Pacific Biologics and Biosimilars Sales by Region	39
8.4.2 China	40
8.4.3 Japan	40
8.4.4 South Korea	40
8.4.5 India	40
8.4.6 Southeast Asia	40
8.5 South America	40
8.5.1 South America Biologics and Biosimilars Sales by Country	41
8.5.2 Brazil	41
8.5.3 Argentina	41
8.5.4 Columbia	41
8.6 Middle East and Africa	41
8.6.1 Middle East and Africa Biologics and Biosimilars Sales by Region	42
8.6.2 Saudi Arabia	42
8.6.3 UAE	42
8.6.4 Egypt	42
8.6.5 Nigeria	43
8.6.6 South Africa	43
9 Key Companies Profiled	44
9.1 Roche	44
9.1.1 Roche Biologics and Biosimilars Basic Information	44
9.1.2 Roche Biologics and Biosimilars Product Overview	44
9.1.3 Roche Biologics and Biosimilars Product Market Performance	44
9.1.4 Roche Business Overview	45
9.1.5 Roche Biologics and Biosimilars SWOT Analysis	45
9.1.6 Roche Recent Developments	45
9.2 Amgen	46
9.2.1 Amgen Biologics and Biosimilars Basic Information	46
9.2.2 Amgen Biologics and Biosimilars Product Overview	46
9.2.3 Amgen Biologics and Biosimilars Product Market Performance	46
9.2.4 Amgen Business Overview	47
9.2.5 Amgen Biologics and Biosimilars SWOT Analysis	47
9.2.6 Amgen Recent Developments	47
9.3 AbbVie	47
9.3.1 AbbVie Biologics and Biosimilars Basic Information	47
9.3.2 AbbVie Biologics and Biosimilars Product Overview	48
9.3.3 AbbVie Biologics and Biosimilars Product Market Performance	48
9.3.4 AbbVie Business Overview	48
9.3.5 AbbVie Biologics and Biosimilars SWOT Analysis	49
9.3.6 AbbVie Recent Developments	49
9.4 Sanofi-Aventis	49
9.4.1 Sanofi-Aventis Biologics and Biosimilars Basic Information	49
9.4.2 Sanofi-Aventis Biologics and Biosimilars Product Overview	50
9.4.3 Sanofi-Aventis Biologics and Biosimilars Product Market Performance	50
9.4.4 Sanofi-Aventis Business Overview	50
9.4.5 Sanofi-Aventis Biologics and Biosimilars SWOT Analysis	50
9.4.6 Sanofi-Aventis Recent Developments	51
9.5 Johnson & Johnson	51
9.5.1 Johnson & Johnson Biologics and Biosimilars Basic Information	51
9.5.2 Johnson & Johnson Biologics and Biosimilars Product Overview	51
9.5.3 Johnson & Johnson Biologics and Biosimilars Product Market Performance	52
9.5.4 Johnson & Johnson Business Overview	52
9.5.5 Johnson & Johnson Biologics and Biosimilars SWOT Analysis	52
9.5.6 Johnson & Johnson Recent Developments	52
9.6 Pfizer	53
9.6.1 Pfizer Biologics and Biosimilars Basic Information	53
9.6.2 Pfizer Biologics and Biosimilars Product Overview	53
9.6.3 Pfizer Biologics and Biosimilars Product Market Performance	53
9.6.4 Pfizer Business Overview	54
9.6.5 Pfizer Recent Developments	54
9.7 Novo Nordisk	54
9.7.1 Novo Nordisk Biologics and Biosimilars Basic Information	54
9.7.2 Novo Nordisk Biologics and Biosimilars Product Overview	55
9.7.3 Novo Nordisk Biologics and Biosimilars Product Market Performance	55
9.7.4 Novo Nordisk Business Overview	55
9.7.5 Novo Nordisk Recent Developments	55
9.8 Eli Lilly	56
9.8.1 Eli Lilly Biologics and Biosimilars Basic Information	56
9.8.2 Eli Lilly Biologics and Biosimilars Product Overview	56
9.8.3 Eli Lilly Biologics and Biosimilars Product Market Performance	56
9.8.4 Eli Lilly Business Overview	57
9.8.5 Eli Lilly Recent Developments	57
9.9 Novartis	57
9.9.1 Novartis Biologics and Biosimilars Basic Information	57
9.9.2 Novartis Biologics and Biosimilars Product Overview	58
9.9.3 Novartis Biologics and Biosimilars Product Market Performance	58
9.9.4 Novartis Business Overview	58
9.9.5 Novartis Recent Developments	58
9.10 Merck	59
9.10.1 Merck Biologics and Biosimilars Basic Information	59
9.10.2 Merck Biologics and Biosimilars Product Overview	59
9.10.3 Merck Biologics and Biosimilars Product Market Performance	59
9.10.4 Merck Business Overview	60
9.10.5 Merck Recent Developments	60
9.11 3sbio	60
9.11.1 3sbio Biologics and Biosimilars Basic Information	60
9.11.2 3sbio Biologics and Biosimilars Product Overview	61
9.11.3 3sbio Biologics and Biosimilars Product Market Performance	61
9.11.4 3sbio Business Overview	61
9.11.5 3sbio Recent Developments	61
9.12 Changchun High Tech	62
9.12.1 Changchun High Tech Biologics and Biosimilars Basic Information	62
9.12.2 Changchun High Tech Biologics and Biosimilars Product Overview	62
9.12.3 Changchun High Tech Biologics and Biosimilars Product Market Performance	62
9.12.4 Changchun High Tech Business Overview	63
9.12.5 Changchun High Tech Recent Developments	63
9.13 CP Guojian	63
9.13.1 CP Guojian Biologics and Biosimilars Basic Information	63
9.13.2 CP Guojian Biologics and Biosimilars Product Overview	64
9.13.3 CP Guojian Biologics and Biosimilars Product Market Performance	64
9.13.4 CP Guojian Business Overview	64
9.13.5 CP Guojian Recent Developments	64
9.14 Biotech	65
9.14.1 Biotech Biologics and Biosimilars Basic Information	65
9.14.2 Biotech Biologics and Biosimilars Product Overview	65
9.14.3 Biotech Biologics and Biosimilars Product Market Performance	65
9.14.4 Biotech Business Overview	66
9.14.5 Biotech Recent Developments	66
9.15 Gelgen	66
9.15.1 Gelgen Biologics and Biosimilars Basic Information	66
9.15.2 Gelgen Biologics and Biosimilars Product Overview	67
9.15.3 Gelgen Biologics and Biosimilars Product Market Performance	67
9.15.4 Gelgen Business Overview	67
9.15.5 Gelgen Recent Developments	67
9.16 Innovent	68
9.16.1 Innovent Biologics and Biosimilars Basic Information	68
9.16.2 Innovent Biologics and Biosimilars Product Overview	68
9.16.3 Innovent Biologics and Biosimilars Product Market Performance	68
9.16.4 Innovent Business Overview	69
9.16.5 Innovent Recent Developments	69
9.17 Dong Bao	69
9.17.1 Dong Bao Biologics and Biosimilars Basic Information	69
9.17.2 Dong Bao Biologics and Biosimilars Product Overview	70
9.17.3 Dong Bao Biologics and Biosimilars Product Market Performance	70
9.17.4 Dong Bao Business Overview	70
9.17.5 Dong Bao Recent Developments	70
9.18 Ganlee	71
9.18.1 Ganlee Biologics and Biosimilars Basic Information	71
9.18.2 Ganlee Biologics and Biosimilars Product Overview	71
9.18.3 Ganlee Biologics and Biosimilars Product Market Performance	71
9.18.4 Ganlee Business Overview	72
9.18.5 Ganlee Recent Developments	72
9.19 United Laboratories	72
9.19.1 United Laboratories Biologics and Biosimilars Basic Information	72
9.19.2 United Laboratories Biologics and Biosimilars Product Overview	73
9.19.3 United Laboratories Biologics and Biosimilars Product Market Performance	73
9.19.4 United Laboratories Business Overview	73
9.19.5 United Laboratories Recent Developments	73
10 Biologics and Biosimilars Market Forecast by Region	106
10.1 Global Biologics and Biosimilars Market Size Forecast	106
10.2 Global Biologics and Biosimilars Market Forecast by Region	106
10.2.1 North America Market Size Forecast by Country	107
10.2.2 Europe Biologics and Biosimilars Market Size Forecast by Country	108
10.2.3 Asia Pacific Biologics and Biosimilars Market Size Forecast by Region	108
10.2.4 South America Biologics and Biosimilars Market Size Forecast by Country	109
10.2.5 Middle East and Africa Forecasted Consumption of Biologics and Biosimilars by Country	109
11 Forecast Market by Type and by Application (2022-2028)	111
11.1 Global Biologics and Biosimilars Market Forecast by Type (2022-2028)	111
11.1.1 Global Forecasted Sales of Biologics and Biosimilars by Type (2022-2028)	111
11.1.2 Global Biologics and Biosimilars Market Size Forecast by Type (2022-2028)	111
11.1.3 Global Forecasted Price of Biologics and Biosimilars by Type (2022-2028)	112
11.2 Global Biologics and Biosimilars Market Forecast by Application (2022-2028)	112
11.2.1 Global Biologics and Biosimilars Sales (K Units) Forecast by Application	112
11.2.2 Global Biologics and Biosimilars Market Size (M USD) Forecast by Application (2022-2028)	113
12 Conclusion and Key Findings	114
List of Tables
Table 1. Global Biologics and Biosimilars Sales (K Units) by Manufacturers (2017-2022)	1
Table 2. Global Biologics and Biosimilars Sales Market Share by Manufacturers (2017-2022)	2
Table 3. Global Biologics and Biosimilars Revenue (M USD) by Manufacturers (2017-2022)	3
Table 4. Global Biologics and Biosimilars Revenue Share by Manufacturers (2017-2022)	3
Table 5. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2020)	4
Table 6. Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers (2017-2022)	5
Table 7. Manufacturers Biologics and Biosimilars Sales Sites and Area Served	6
Table 8. Manufacturers Biologics and Biosimilars Product Type	6
Table 9. Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)	8
Table 10. Mergers & Acquisitions, Expansion Plans	9
Table 11. Industry Chain Map of Biologics and Biosimilars	10
Table 12. Raw Materials	10
Table 13. Midstream Market Analysis	11
Table 14. Downstream Customer Analysis	11
Table 15. Key Development Trends	13
Table 16. Driving Factors	13
Table 17. Biologics and Biosimilars Market Challenges	13
Table 18. Market Restraints	14
Table 19. Global Biologics and Biosimilars Sales by Type (K Units)	15
Table 20. Global Biologics and Biosimilars Market Size by Type (M USD)	16
Table 21. Global Biologics and Biosimilars Sales (K Units) by Type (2017-2022)	16
Table 22. Global Biologics and Biosimilars Sales Market Share by Type (2017-2022)	16
Table 23. Global Biologics and Biosimilars Market Size (M USD) by Type (2017-2022)	17
Table 24. Global Biologics and Biosimilars Market Size Share by Type (2017-2022)	17
Table 25. Global Biologics and Biosimilars Price (USD/Unit) by Type (2017-2022)	18
Table 26. Global Biologics and Biosimilars Sales (K Units) by Application	19
Table 27. Global Biologics and Biosimilars Market Size by Application	20
Table 28. Global Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)	20
Table 29. Global Biologics and Biosimilars Sales Market Share by Application (2017-2022)	20
Table 30. Global Biologics and Biosimilars Sales by Application (2017-2022) & (M USD)	21
Table 31. Global Biologics and Biosimilars Market Share by Application (2017-2022)	21
Table 32. Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022)	22
Table 33. Global Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)	23
Table 34. Global Biologics and Biosimilars Sales Market Share by Region (2017-2022)	23
Table 35. North America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)	24
Table 36. Europe Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)	26
Table 37. Asia Pacific Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)	27
Table 38. South America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)	29
Table 39. Middle East and Africa Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)	30
Table 40. Roche Biologics and Biosimilars Basic Information	32
Table 41. Roche Biologics and Biosimilars Product Overview	32
Table 42. Roche Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	32
Table 43. Roche Business Overview	33
Table 44. Roche Biologics and Biosimilars SWOT Analysis	33
Table 45. Roche Recent Developments	33
Table 46. Amgen Biologics and Biosimilars Basic Information	34
Table 47. Amgen Biologics and Biosimilars Product Overview	34
Table 48. Amgen Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	34
Table 49. Amgen Business Overview	35
Table 50. Amgen Biologics and Biosimilars SWOT Analysis	35
Table 51. Amgen Recent Developments	35
Table 52. AbbVie Biologics and Biosimilars Basic Information	35
Table 53. AbbVie Biologics and Biosimilars Product Overview	36
Table 54. AbbVie Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	36
Table 55. AbbVie Business Overview	36
Table 56. AbbVie Biologics and Biosimilars SWOT Analysis	37
Table 57. AbbVie Recent Developments	37
Table 58. Sanofi-Aventis Biologics and Biosimilars Basic Information	37
Table 59. Sanofi-Aventis Biologics and Biosimilars Product Overview	38
Table 60. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	38
Table 61. Sanofi-Aventis Business Overview	38
Table 62. Sanofi-Aventis Biologics and Biosimilars SWOT Analysis	38
Table 63. Sanofi-Aventis Recent Developments	39
Table 64. Johnson & Johnson Biologics and Biosimilars Basic Information	39
Table 65. Johnson & Johnson Biologics and Biosimilars Product Overview	39
Table 66. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	40
Table 67. Johnson & Johnson Business Overview	40
Table 68. Johnson & Johnson Biologics and Biosimilars SWOT Analysis	40
Table 69. Johnson & Johnson Recent Developments	40
Table 70. Pfizer Biologics and Biosimilars Basic Information	41
Table 71. Pfizer Biologics and Biosimilars Product Overview	41
Table 72. Pfizer Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	41
Table 73. Pfizer Business Overview	42
Table 74. Pfizer Recent Developments	42
Table 75. Novo Nordisk Biologics and Biosimilars Basic Information	42
Table 76. Novo Nordisk Biologics and Biosimilars Product Overview	43
Table 77. Novo Nordisk Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	43
Table 78. Novo Nordisk Business Overview	43
Table 79. Novo Nordisk Recent Developments	43
Table 80. Eli Lilly Biologics and Biosimilars Basic Information	44
Table 81. Eli Lilly Biologics and Biosimilars Product Overview	44
Table 82. Eli Lilly Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	44
Table 83. Eli Lilly Business Overview	45
Table 84. Eli Lilly Recent Developments	45
Table 85. Novartis Biologics and Biosimilars Basic Information	45
Table 86. Novartis Biologics and Biosimilars Product Overview	46
Table 87. Novartis Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	46
Table 88. Novartis Business Overview	46
Table 89. Novartis Recent Developments	46
Table 90. Merck Biologics and Biosimilars Basic Information	47
Table 91. Merck Biologics and Biosimilars Product Overview	47
Table 92. Merck Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	47
Table 93. Merck Business Overview	48
Table 94. Merck Recent Developments	48
Table 95. 3sbio Biologics and Biosimilars Basic Information	48
Table 96. 3sbio Biologics and Biosimilars Product Overview	49
Table 97. 3sbio Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	49
Table 98. 3sbio Business Overview	49
Table 99. 3sbio Recent Developments	49
Table 100. Changchun High Tech Biologics and Biosimilars Basic Information	50
Table 101. Changchun High Tech Biologics and Biosimilars Product Overview	50
Table 102. Changchun High Tech Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	50
Table 103. Changchun High Tech Business Overview	51
Table 104. Changchun High Tech Recent Developments	51
Table 105. CP Guojian Biologics and Biosimilars Basic Information	51
Table 106. CP Guojian Biologics and Biosimilars Product Overview	52
Table 107. CP Guojian Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	52
Table 108. CP Guojian Business Overview	52
Table 109. CP Guojian Recent Developments	52
Table 110. Biotech Biologics and Biosimilars Basic Information	53
Table 111. Biotech Biologics and Biosimilars Product Overview	53
Table 112. Biotech Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	53
Table 113. Biotech Business Overview	54
Table 114. Biotech Recent Developments	54
Table 115. Gelgen Biologics and Biosimilars Basic Information	54
Table 116. Gelgen Biologics and Biosimilars Product Overview	55
Table 117. Gelgen Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin
 (2017-2022)	55
Table 118. Gelgen Business Overview	55
Table 119. Gelgen Recent Developments	55
Table 120. Innovent Biologics and Biosimilars Basic Information	56
Table 121. Innovent Biologics and Biosimilars Product Overview	56
Table 122. Innovent Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	56
Table 123. Innovent Business Overview	57
Table 124. Innovent Recent Developments	57
Table 125. Dong Bao Biologics and Biosimilars Basic Information	57
Table 126. Dong Bao Biologics and Biosimilars Product Overview	58
Table 127. Dong Bao Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	58
Table 128. Dong Bao Business Overview	58
Table 129. Dong Bao Recent Developments	58
Table 130. Ganlee Biologics and Biosimilars Basic Information	59
Table 131. Ganlee Biologics and Biosimilars Product Overview	59
Table 132. Ganlee Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	59
Table 133. Ganlee Business Overview	60
Table 134. Ganlee Recent Developments	60
Table 135. United Laboratories Biologics and Biosimilars Basic Information	60
Table 136. United Laboratories Biologics and Biosimilars Product Overview	61
Table 137. United Laboratories Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)	61
Table 138. United Laboratories Business Overview	61
Table 139. United Laboratories Recent Developments	61
Table 140. Global Biologics and Biosimilars Sales Forecast by Region (K Units)	94
Table 141. Global Biologics and Biosimilars Market Size Forecast by Region (M USD)	95
Table 142. North America Biologics and Biosimilars Sales Forecast by Country (2022-2028) & (K Units)	95
Table 143. North America Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD)	95
Table 144. Europe Biologics and Biosimilars Sales Forecast by Country (2022-2028) & (K Units)	96
Table 145. Europe Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD)	96
Table 146. Asia Pacific Biologics and Biosimilars Sales Forecast by Region (2022-2028) & (K Units)	96
Table 147. Asia Pacific Biologics and Biosimilars Market Size Forecast by Region (2022-2028) & (M USD)	97
Table 148. South America Biologics and Biosimilars Sales Forecast by Country (2022-2028) & (K Units)	97
Table 149. South America Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD)	97
Table 150. Middle East and Africa Biologics and Biosimilars Consumption Forecast by Country (2022-2028) & (Units)	97
Table 151. Middle East and Africa Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD)	98
Table 152. Global Biologics and Biosimilars Sales Forecast by Type (2022-2028) & (K Units)	99
Table 153. Global Biologics and Biosimilars Market Size Forecast by Type (2022-2028) & (M USD)	99
Table 154. Global Biologics and Biosimilars Price Forecast by Type (2022-2028) & (USD/Unit)	100
Table 155. Global Biologics and Biosimilars Sales (K Units) Forecast by Application (2022-2028)	100
Table 156. Global Biologics and Biosimilars Market Size Forecast by Application (2022-2028) & (M USD)	101
LIST OF FIGURES
Figure 1. Biologics and Biosimilars Sales Share by Manufacturers in 2020	2
Figure 2. Global Biologics and Biosimilars Revenue Share by Manufacturers in 2020	4
Figure 3. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020	5
Figure 4. Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers in 2020	6
Figure 5. The Global 5 and 10 Largest Players: Market Share by Biologics and Biosimilars Revenue in 2020	9
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)	15
Figure 7. Global Biologics and Biosimilars Market Share by Type	16
Figure 8. Sales Market Share of Biologics and Biosimilars by Type (2017-2022)	17
Figure 9. Sales Market Share of Biologics and Biosimilars by Type in 2020	17
Figure 10. Market Size Share of Biologics and Biosimilars by Type (2017-2022)	17
Figure 11. Market Size Market Share of Biologics and Biosimilars by Type in 2020	18
Figure 12. Global Biologics and Biosimilars Market Share by Application	20
Figure 13. Global Biologics and Biosimilars Sales Market Share by Application (2017-2022)	21
Figure 14. Global Biologics and Biosimilars Sales Market Share by Application in 2020	21
Figure 15. Global Biologics and Biosimilars Market Share by Application (2017-2022)	22
Figure 16. Global Biologics and Biosimilars Market Share by Application in 2020	22
Figure 17. Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022)	22
Figure 18. Global Biologics and Biosimilars Sales Market Share by Region (2017-2022)	23
Figure 19. North America Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	24
Figure 20. North America Biologics and Biosimilars Sales Market Share by Country in 2020	24
Figure 21. U.S. Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	25
Figure 22. Canada Biologics and Biosimilars Sales (K Units) and Growth Rate (2017-2022)	25
Figure 23. Mexico Biologics and Biosimilars Sales (Units) and Growth Rate (2017-2022)	25
Figure 24. Europe Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	25
Figure 25. Europe Biologics and Biosimilars Sales Market Share by Country in 2020	26
Figure 26. Germany Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	26
Figure 27. France Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	26
Figure 28. U.K. Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	26
Figure 29. Italy Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	27
Figure 30. Russia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	27
Figure 31. Asia Pacific Biologics and Biosimilars Sales and Growth Rate (K Units)	27
Figure 32. Asia Pacific Biologics and Biosimilars Sales Market Share by Region in 2020	27
Figure 33. China Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	28
Figure 34. Japan Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	28
Figure 35. South Korea Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	28
Figure 36. India Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	28
Figure 37. Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	28
Figure 38. South America Biologics and Biosimilars Sales and Growth Rate (K Units)	28
Figure 39. South America Biologics and Biosimilars Sales Market Share by Country in 2020	29
Figure 40. Brazil Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	29
Figure 41. Argentina Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	29
Figure 42. Columbia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	29
Figure 43. Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (K Units)	29
Figure 44. Middle East and Africa Biologics and Biosimilars Sales Market Share by Region in 2020	30
Figure 45. Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	30
Figure 46. UAE Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	30
Figure 47. Egypt Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	30
Figure 48. Nigeria Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	31
Figure 49. South Africa Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units)	31
Figure 50. Global Biologics and Biosimilars Sales Forecast by Volume (2017-2028) & (K Units)	94
Figure 51. Global Biologics and Biosimilars Market Size Forecast by Value (2017-2028) & (M USD)	94
Figure 52. Global Biologics and Biosimilars Sales Market Share Forecast by Type (2022-2028)	99
Figure 53. Global Biologics and Biosimilars Market Share Forecast by Type (2022-2028)	99
Figure 54. Global Biologics and Biosimilars Sales Forecast by Application (2022-2028)	100
Figure 55. Global Biologics and Biosimilars Market Share Forecast by Application (2022-2028)	101
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Frequently Asked Questions
Global Biologics and Biosimilars Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Biologics and Biosimilars Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Biologics and Biosimilars Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports